JAMTEKI
Analogs of JAMTEKI
Find cheaper analogs and generic equivalents for JAMTEKI.
Active Ingredient: USTEKINUMAB
Product Overview
About JAMTEKI
JAMTEKI is a prescription medication containing the active ingredient USTEKINUMAB, a human monoclonal antibody that selectively targets and binds to the p40 subunit of interleukin-12 (IL-12) and interleukin-23 (IL-23). This medication is used to treat moderate to severe plaque psoriasis in adults, as well as psoriatic arthritis.
Key Benefits & Uses
- Treatment of moderate to severe plaque psoriasis in adults
- Treatment of psoriatic arthritis in adults
- Reduction of signs and symptoms of psoriatic arthritis
Active Ingredient & Action
USTEKINUMAB works by binding to the p40 subunit of IL-12 and IL-23, thereby inhibiting the activation of T helper 1 (Th1) cells and the production of pro-inflammatory cytokines. This leads to a decrease in the severity of psoriasis symptoms and the reduction of inflammation in the joints.
Important Notes
JAMTEKI should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions to minimize the risk of adverse effects. Patients with a history of tuberculosis or latent tuberculosis infection should be evaluated before starting treatment with JAMTEKI. Regular monitoring of liver function and blood counts is recommended during treatment.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.